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Dietary polyunsaturated fatty acid (PUFA) manipulation is being investigated as a potential
therapeutic supplement to reduce the risk of developing age-related cognitive decline
(ARCD). Animal studies suggest that high omega ()-3 and low -6 dietary content
reduces cognitive decline by decreasing central nervous system (CNS) inflammation and
modifying neuroimmune activity. However, no previous studies have investigated the long
term effects of -3 and -6 dietary levels in healthy aging mice leaving the important
question about the preventive effects of -3 and -6 on behavior and underlying molecular
pathways unaddressed. We aimed to investigate the efficacy of long-term -3 and -6
PUFA dietary supplementation in mature adult C57BL/6 mice. We measured the effect
of low, medium, and high -3:-6 dietary ratio, given from the age of 3–7 months, on
anxiety and cognition-like behavior, hippocampal tissue expression of TNF-α, markers of
neuronal progenitor proliferation and gliogenesis and serum cytokine concentration. Our
results show that a higher -3:-6 PUFA diet ratio increased hippocampal PUFA, increased
anxiety, improved hippocampal dependent spatial memory and reduced hippocampal
TNF-α levels compared to a low -3:-6 diet. Furthermore, serum TNF-α concentration
was reduced in the higher -3:-6 PUFA ratio supplementation group while expression of
the neuronal progenitor proliferation markers KI67 and doublecortin (DCX) was increased
in the dentate gyrus as opposed to the low -3:-6 group. Conversely, -3:-6 dietary
PUFA ratio had no significant effect on astrocyte or microglia number or cell death in the
dentate gyrus. These results suggest that supplementation of PUFAs may delay aging
effects on cognitive function in unchallenged mature adult C57BL/6 mice. This effect is
possibly induced by increasing neuronal progenitor proliferation and reducing TNF-α.
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INTRODUCTION
The role of diet in the maintenance of mental health has long
been recognized. Evidence suggests that the typical western diet is
detrimental to the maintenance of cognitive function with aging
(Francis and Stevenson, 2013). Recently, dietary interventions
aimed at preventing cognitive decline have received attention,
as it appears that diet across the entire lifespan plays a complex
role in the development of cognitive decline (Gillette-Guyonnet
et al., 2013). This suggests that early intervention, for example,
up to middle age, may have more substantial benefits on cogni-
tive function in later life as opposed to interventions in the elderly
only.
Clinical trials have established that supplementation with
omega ()-3, or a combination of -3 and -6 may have a role
in the management and prevention of mild cognitive impairment
(MCI) (Yehuda et al., 1996; Freund-Levi et al., 2006; Chiu et al.,
2008; Yurko-Mauro et al., 2010). Animal studies demonstrate
improved spatial recognition memory in aged mice after 7 weeks
or 2 months of -3 polyunsaturated fatty acid (PUFA) supple-
mentation (Jiang et al., 2009; Labrousse et al., 2012). Previous
investigation into the mechanisms of this effect suggest that -3
PUFA supplementation has anti-inflammatory properties in aged
mice (Labrousse et al., 2012) and increases neurogenesis in young
mice (Kawakita et al., 2006), through stimulating brain derived
neurotrophic factor (BDNF) and tropomyosin receptor kinase B
(TrkB) expression (Jiang et al., 2009; Valente et al., 2009; Bhatia
et al., 2011). Furthermore, it appears to reduce neuronal apoptosis
after induced hypoxic injury (Zhang et al., 2010) through increas-
ing anti-apoptotic proteins (Bcl-xl, Bcl-2, Bfl-1), while decreasing
pro-apoptotic proteins (Bax, Bik) (Lukiw et al., 2005). It is also
important to note that increased -6, or a low ratio of 3:6, is
also associated with impaired cognition and behavior in animal
and human studies (Loef and Walach, 2013; Van Elst et al., 2014),
although few studies have looked at this to date.
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Thus, far the effects of dietary intervention on cognition in
mature mice up to 7 months of age, before the onset of any mea-
surable impairment, have yet to be investigated. Furthermore,
the majority of studies investigating -3 and -6 PUFA supple-
mentation in animal models of cognitive dysfunction have used
short term (≤ 2 months) supplementation (Minogue et al., 2007;
Petursdottir et al., 2008; Suchy et al., 2009; Labrousse et al., 2012),
or -3 supplementation in animals previously deficient in -
3 (Hashimoto et al., 2002, 2005, 2009; McNamara et al., 2010).
A recent systematic review suggested that long term -3 sup-
plementation (>10% of animals lifespan) was most effective in
reducing amyloid pathology and improving cognitive function
(Hooijmans et al., 2012). Currently, studies that have examined
a longer period of supplementation (3–12 months) have largely
been limited to murine models of genetic predisposition to AD
(Calon et al., 2004, 2005; Oksman et al., 2006; Arendash et al.,
2007; Hooijmans et al., 2007; Arsenault et al., 2011). One such
study in APPswe/PS1E9 mice over 7 months found no signifi-
cant protective effect (Arendash et al., 2007), while another study
in 3xTG-ADmice identified that a high-3 diet improved explo-
ration time (Arsenault et al., 2011). As diet is likely to affect
predisposition to cognitive decline across the lifespan, the effects
of modifying -3--6 dietary intake supplementation until close
to middle age (7 months of age) is important to consider.
Our study aimed to examine the preventative effect of long-
term (∼60% of lifetime) high -3:-6 dietary supplementation
on predisposition to cognitive decline, and to examine the under-
lying mechanisms of this effect. While many people may only
start to increase their intake of -3 dietary supplementation later
in life, longer periods of supplementation may be more benefi-
cial in the prevention of chronic disease such as cognitive decline
(Simopoulos, 2011). This study utilized three different diets, a low
-3:-6 ratio diet, a medium -3:-6 ratio diet and a high -
3:-6 ratio diet. Thus, the dose-related and -3:-6 ratio related
effects of PUFA dietary modification on cognition-like behav-
ior, neuroinflammation and neuronal progenitor proliferation in
C57BL/6 mice were investigated.
METHODS AND MATERIALS
ANIMALS AND DIET
Male (n = 18) and female (n = 12) C57BL/6NHsd mice, start-
ing age 3 months, were used throughout the experiments. Ad
libitum fed mice were housed in Laboratory Animal Services
(LAS) Adelaide approved conditions with 3–5 animals per cage
in individually ventilated cages (IVC) with a 12 h light/dark cycle.
Handling and a general health examination including weighing of
mice occurred twice per week. This study received ethics approval
from the University of Adelaide animal ethics committee.
Mice were fed the AIN-93G mouse feed purchased from
Specialty Feeds (Western Australia) from time of weaning until
3 months of age to ensure adequate growth and cognitive devel-
opment. At 3 months of age, mice were randomly separated into
three diet groups: low -3:-6, medium -3:-6, and high -
3:-6. The low -3:-6 diet incorporated 0.6 g/kg -3, with a
1:29 ratio of -3:-6, representing a similar -3:-6 ratio to
current western diets (Blasbalg et al., 2011). The medium -3:-
6 diet incorporated 4.2 g/kg -3 with a 1:3.6 ratio of -3:-6,
approximately similar to estimated human consumption in the
year 1909 (1:6.7) (Blasbalg et al., 2011) and the estimated tra-
ditional evolutionary -3:-6 ratio (1:1) (Simopoulos, 2011),
which is predicted to be more beneficial than the current intake
levels (Simopoulos, 2011). The high -3:-6 diet incorporated
14.2 g/kg -3 with a 2:1 ratio of -3:-6, a level of supple-
mentation beyond what could reasonably be achieved through
modifying dietary intake to a more traditional composition
(Simopoulos, 2011). For an overview of the fat content of each
diet refer to Table 1. Modified diets were based on the AIN-93M
adult mouse diet with 5% total fat and only differed in proportion
of dietary fatty acids. The AIN-93G and AIN-93M mouse diets
are formulations of feed designed for optimal animal health, with
a known composition (Reeves et al., 1993). Diet was stored as dry
pellets in a sealed vacuum container until required. Once opened,
feed was stored at 4◦C. A full analysis of the composition of each
diet is available in the supplementary information. The medium
3:6 diet had fatty acid levels similar to those found in normal
rodent chow used in the animal facility (Meat Free Rat andMouse
Diet (Speciality Feeds): total fat content 5%, total n − 30.37%,
total n − 61.31%, with a CV of 43% and 6% respectively). Mice
were fed the modified diets for 4 months. A total of 30 mice
[WT: low -3:-6 n = 10 (7 male + 3 female), medium -3:-
6 n = 10 (6 male + 4 female), high -3:-6 n = 10 (5 male +
5 female)], aged 7 months (middle age), were used for behav-
ioral analyses. There were no differences in outcomes observed
between male and female mice in any of the treatment groups.
Due to the loose consistency of the feed pellets, many of which
disintegrated and fell into the cage, we were unable to measure
food intake.
ASSESSMENT OF COGNITION-LIKE BEHAVIOR
Open field
The open field test was used to assess general locomotor activity
and anxiety like behavior. It consists of a 40 × 40 cm box with
Table 1 | Composition of fatty acids in experimental diets (% weight
of total fatty acids).
Diets Low -3:-6 Med. -3:-6 High -3:-6
Total -6 1.76 1.52 0.70
ARA trace 0.02 0.07
LA 1.75 1.48 0.56
Total -3 0.06 0.42 1.42
ALA 0.04 0.03 0.02
EPA Trace 0.06 0.23
DHA 0.04 0.28 1.03
MUFA 1.30 1.27 1.17
PUFA 1.82 1.95 2.14
SFA 1.69 1.59 1.40
-3:-6 1:29 1:3.6 2:1
Composition of fatty acids in each diet, as a percentage of weight in the overall
diet. -3 and -6 PUFA concentrations were achieved through altering quanti-
ties of clarified butter, maize oil and Numega Tuna oil. ARA, Arachidonic acid;
LA, linolenic acid; ALA, alpha-Linolenic acid; EPA, Eicosapentaenoic acid; DHA,
Docosahexaenoic acid; MUFA, monounsaturated fatty acid; PUFA, polyunsatu-
rated fatty acid; SFA, saturated fatty acid.
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black walls 35 cm high into which each mouse was placed for
5min while behavior was recorded according to published pro-
tocols (Baune et al., 2008; Gould et al., 2009; Hart et al., 2010).
ANYMAZE recording software (v 4.98) was used to record total
distance traveled and time spent in center.
Barnes Maze
The Barnes Maze was used to assess spatial learning and mem-
ory. It consists of an elevated circular table (91 cm), 90 cm above
the ground, with 20 circular holes evenly distributed around the
periphery of the table. One hole lead to an escape box of sufficient
size to house the mouse comfortably while the remaining 19 holes
lead to false boxes of insufficient size to house the mouse. Bright
overhead lighting provided incentive for the mouse to escape
the exposed circular platform by locating the escape box. Barnes
Maze procedures were carried out according to published proto-
cols (McLay et al., 1998; Baune et al., 2008; McAfoose et al., 2009).
Mice underwent 4 days of training during which each mouse was
placed in the center of the apparatus under a cover which was
removed at the beginning of the trial. If the escape hole was not
located within 3min, the mouse was gently directed toward the
escape hole, followed by relocation to the home cage. The appara-
tus was cleaned with 70% ethanol between each trial to eliminate
olfactory cues. Each mouse received 3 trials per day separated
by 15min. The average latency of the three trials was recorded.
On day 5 two probe trials were given for 3min each. The table
was rotated so that the escape box was 90◦ (probe trial 1) and
180◦ (probe trial 2) from the original training position. Rotating
the table and position of the hole should counteract any olfac-
tory cues used to find the old location, as in a traditional probe
trial with no hole. Time to find the old location of the escape
box and time to find the new location were recorded. Latency to
find the new location gives an indication that the mice learns the
escape box has moved and tries to find it in a new position. Probe
trial 2 should act as a type of extinction trial, where mice should
no longer go straight to the old location (data is not shown).
All movements, including latency to find the escape box were
recorded using ANYMAZE software.
MOLECULAR ANALYSES
Tissue processing
Each mouse was injected with pentobarbitone (60mg/kg).
Adequate anesthesia was determined by the absence of limb and
corneal reflexes. Blood was collected via cardiac puncture from
half of the mice after which their brains were retrieved, fresh
frozen in liquid nitrogen and stored at −80◦C for future protein
analysis (WT: low -3:-6 n = 5, medium -3:-6 n = 5, high
-3:-6 n = 5). The remaining halves of each treatment group
were prepared for immunohistochemistry (IHC). These mice
were perfused with a 10ml of 10% formalin solution through the
left ventricle followed by retrieval of brain tissue and storage in
10% formalin (low-3:-6 n = 5, medium-3:-6 n = 5, high
-3:-6 n = 5).
Serum cytokine quantification
Blood was centrifuged at 2500 rpm for 10min, at least 30min
following collection, and serum was collected. Serum cytokine
levels were measured using the BD Biosciences Cytometric Bead
Array (CBA) Mouse Inflammation Kit for the cytokines inter-
leukin (IL)-6, IL-10, monocyte chemoattractant protein (MCP)-
1, interferon (IFN)-γ, TNF-α, and IL-12p70 according to the
manufacturer’s instructions. The theoretical lower detection per
cytokine was; 5 pg/ml for IL-6, 17 pg/ml for IL-10, 52.7 pg/ml for
MCP-1, 2.5 pg/ml for IFN-γ, 7.3 pg/ml for TNF-α and 10.7 pg/ml
for IL-12p70. The Aria (Beckman Coulter) was used to acquire
3000 events for each sample. Individual cytokine concentrations
were identified by their fluorescent intensities (Fl-2) and were
computed using the individual cytokine standard reference curve
using the FCAP Array v3 software (BD Biosciences).
Immunohistochemistry
Brains were embedded in paraffin prior to sectioning, with a
series of nine 5μm sections collected at 200μm intervals from
Bregma −1.3 to −3.1, allowing a comprehensive analysis of
the hippocampus. Immunohistochemistry was then performed
to examine levels of TNF-α (R&D: AF410-NA), doublecortin
(DCX) (Millipore: AB2293), Ki67 (Abcam: AB15580), GFAP
(Novocastra: NCL:GFAP:GA5), IBA-1 (Santa-Cruz: 28528),
caspase-3 (Biovision: 3138-100), and oxo8dG/oxo8G (QED
Bioscience 12501). Following de-waxing and dehydration,
endogenous peroxidase activity was blocked by incubation with
0.5% hydrogen peroxide in methanol for 30min. Slides were then
washed 2 × 3min in phosphate buffered saline (PBS) before anti-
gen retrieval by heating at close to boiling point for 10min (TRIS
for doublecortin, citrate for others). Once the slides had cooled
below 40◦C they were washed with PBS before being blocked
with 3% normal horse serum in PBS for 30min. The appropri-
ate primary antibody was applied to the slides which were left
to incubate at room temperature overnight (TNF-α 1:300, IBA-
1 1:1000, caspase-3 1:1000, Ki67 1:2000, doublecortin 1:8000,
GFAP 1:40000, oxo8dG/oxo8G 1:8000).
The next day slides were washed in 2 × 3min of PBS before
the appropriate species of IgG biotintylated antibody was added
for 30min (Dako). After another PBS wash, slides were incubated
with streptavidin peroxidase conjugate for 60min followed by
another rinse with PBS. The immunocomplex was then visual-
ized with precipitation of DAB (Sigma D-5637) in the presence
of hydrogen peroxide. Slides were washed to remove excess DAB
and lightly counterstained with haematoxylin, dehydrated and
mounted with DePeX from histolene.
Slides were subsequently digitally scanned using the
Hamamatsu NanoZoomer and examined using the associ-
ated NDP.view2 software (Hamamatsu). Sequential images were
captured of the hippocampus consisting of the cornu ammonis,
dentate gyrus and hippocampal formation and exported for
manual cell counting using the inbuilt software within Image
J 1.46 (NIH). The number of positive cells were then counted
at 40× magnification within each hippocampus (or dentate
gyrus alone depending on the immunohistochemical stain) of
each slide. For the stains TNF-α, anti-caspase 3, Ki67, and DCX,
all positive cells in the relevant brain areas were counted and
recorded through the use of the cell tracking tool provided with
the software. For GFAP and IBA-1, the image was overlaid with
120 × 120 μm grids, and every second grid for IBA-1 or 10
consistent representative grids for GFAP were counted with the
total being corrected for the total area to determine the number
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of immunopositive cells. The size of the hippocampus or dentate
gyrus was then measured within the NDP view software to
allowing the final measurement to be expressed as cells/mm2. For
oxidative stress, the dentate gyrus region from each mouse was
ranked on a scale from 0 to 3, with 0 = no staining, 1 = light
staining, 2 = moderate staining and 3 = strong staining. The
researcher was blinded to the study group of the slides during
the slide analysis process. The Coefficient of error was calculated
by comparing the total number of immunopositive cells for
each subject within each diet and stain to identify the mean and
standard error of the mean. The Coefficient of error then was the
result of the SEM divided by the Mean. For hippocampal TNFα,
the CE for the for high -3:-6 mice was 0.06, for medium
-3:-6 mice was 0.12 and for low -3:-6 was 0.10. For
TNF-α in the dentate gyrus, the CE was 0.29, 0.21, and 0.31 for
high, medium and low -3:-6 mice, respectively. For DCX the
CE values were 0.17, 0.18, and 0.05 for high, medium and low
-3:-6 mice, respectively. For Ki67 the CE values were 0.17,
0.17, and 0.19 for high, medium and low -3--6 mice. For
GFAP the CE values were 0.04, 0.12, and 0.04 for high medium
and low -3:-6 mice. For IBA-1, CE values were 0.07, 0.06, and
0.08 for high, medium and low -3:-6 mice and for caspase-3
CE values were 0.20, 0.17, and 0.17 for high, medium and low
-3:-6 mice, respectively.
Free fatty acid analyses
Analyses of free fatty acids were carried out by the Waite
Analytical Services. Briefly the standardized protocol extracted
total lipids from thawed hippocampi tissue samples utilizing a
modified Bligh and Dyer method with the addition of heptade-
canoic acid as an internal standard (Tu et al., 2013). Free fatty
acids were separated via thin layer chromatography and methy-
lated and then analyzed via gas chromatography. The resultant
fatty acid methyl esters were identified based on the retention
time of standards obtained by Nucheck Prep Inc. (Elysian MN)
using the Hewlett-Packard Chemstation data system. Free fatty
acids were quantified as a percentage of hippocampal tissue
sample.
STATISTICAL ANALYSES
All data was analyzed using Graphpad PRISM software (ver-
sion 6.02). Data was tested for Gaussian distribution using the
D’Agostino-Pearson omnibus test. All data passed Normality
testing. For Barnes maze learning analysis repeated measures
Two-Way ANOVA with Tukey’s multiple comparisons test was
used, to show whether groups showed significant learning or
not. For all other data, comparisons of the effect of different
diets within mouse strains were tested using One-Way ANOVA
with Tukey’s post-hoc test comparisons. For all results, a p-value
of < 0.05 was considered significant. All data is represented as
mean values ± SEM.
RESULTS
THE EFFECT OF-3:-6 SUPPLEMENTATION ONWEIGHT AND
GENERAL OPEN FIELD MEASURES
Mice were weighed immediately prior to euthanasia. Mice in the
low -3:-6 group (28.5 ± 0.95 g) were found to be significantly
lighter than medium -3:-6 (35.7 ± 1.78 g) and high -3:-
6 diet (34.4 ± 1.73 g) mice (One-Way ANOVA F = 6.28, p =
0.006, Tukey’s post-hoc test p = 0.007, p = 0.029, respectively).
There was however no significant correlation between weight and
anxiety or weight and immunohistochemistry stain count when
analyzed using Pearson correlation.
Differences in locomotor activity were investigated by record-
ing the distance traveled during the Open Field test. No loco-
motor differences were observed between low, medium or high
-3:-6 diet groups (One-Way ANOVA F = 0.14, p = 0.87)
(Figure 1A).
Anxiety-like behavior was measured in the open field test
whereby time spent in the center of the field represents reduced
anxiety-like behavior (Flint, 2003; Hart et al., 2010). One-Way
ANOVA (F = 3.97, p = 0.032) with Tukey’s post-hoc test showed
that mice in the high -3:-6 diet group spent significantly less
time in the center of the open field compared to the low -3:-
6 group (p = 0.047), with a trend to also spend less time than
the medium -3:-6 group (p = 0.068). These results show that
the high -3:-6 diet leads to increased anxiety in the open field
(Figure 1B).
INVESTIGATING EFFECTS OF-3:6 DIETARY SUPPLEMENTATION ON
SPATIAL LEARNING
The Barnes Maze was used to investigate learning behavior as
described. Learning ability was inferred from reduced latency to
locate the escape hole on subsequent training days over 4 days. A
repeated measures Two-Way ANOVAwas used to analyses latency
by Diet and by Day, showing a significant effect of day of train-
ing (F = 13.0, p < 0.0001) but not of diet (F = 0.55, p = 0.59)
or interaction (F = 0.85, p = 0.54) (Figure 2). Tukey’s post-hoc
comparison of day effect suggests that both the medium and high
-3:-6 diet groups showed significant learning over the 4 days,
with latency on Day 1 significantly higher than on Day 4 in both
the medium (p = 0.0047) and high -3:-6 diet groups (p =
0.0004). There were no significant differences between latency on
any days for mice in the low -3:-6 diet group. These observa-
tions suggest that the intake of a high or medium concentration
of dietary -3 PUFA’s improve the ability of mice to learn across
4 days.
Table 2 shows results of the Probe trial 1, where the escape
box was rotated 90◦ from the old location. One-Way ANOVA
showed no difference between diet groups in latency to find the
old location (p = 0.67, F = 0.40) indicating similar spatial mem-
ory across all strains, or in time taken to enter the new location
(p = 0.94, F = 0.06).
EXAMINING EFFECTS OF-3:-6 SUPPLEMENTATION ON SERUM
CYTOKINE EXPRESSION
One-Way ANOVA showed a difference between diet groups in
both IFN-γ (F = 10.3, p = 0.0047) and TNF-α (F = 6.81, p =
0.01). Tukey’s post-hoc analysis indicated that both cytokines
were increased in the low -3:-6 diet group compared to the
medium (IFN-γ p = 0.0068, TNF-α p = 0.029) and high (IFN-γ
p = 0.0078, TNF-α p = 0.014) diet groups (Table 3). No dif-
ferences between diet groups were observed for the remaining
inflammatory markers (IL-6, IL-10, MCP-1, or IL-12; One-Way
ANOVA, all p > 0.05).
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 399 | 4
Grundy et al. Omega-3 supplementation in mice
FIGURE 1 | Locomotor activity and anxiety in the open field. (A)
Locomotor activity of mice in the open field measured by distance traveled
and (B) anxiety-like behavior in mice measured by time spent in the center of
the open field. Data analyzed by One-Way ANOVA within strains with Tukey’s
post-hoc test, ∗p < 0.05, as indicated on figure. All data presented as mean
± SEM (n = 10/group).
FIGURE 2 | Learning behavior in the Barnes Maze. Learning ability of
mice on the Barnes Maze measured by latency to the escape location over
4 days of training. All data represent mean ± SEM (n = 10/group).
Table 2 | Probe Trial measures of Barnes Maze (retention memory).
Time to Find old Time to enter new
escape box location (s) escape box location (s)
Low -3:-6 72.3 ± 22.3 136.8 ± 14.3
Medium -3:-6 89.0 ± 24.6 138.8 ± 19.9
High -3:-6 60.3 ± 17.6 130.1 ± 19.3
Barnes Maze probe trial measures. Data analyzed by One-Way ANOVA. Data
represents mean ± SEM (n = 10/group).
EFFECTS OF-3:-6 SUPPLEMENTATION ON EXPRESSION OF THE
PRO-INFLAMMATORY CYTOKINE TNF-α IN THE HIPPOCAMPUS
The hippocampus (including the cornu ammonis, dentate gyrus
and hippocampal formation) was investigated due to its’ role in
spatial learning and memory (Jarrard, 1993; Rolls and Kesner,
2006; Neves et al., 2008). Within the hippocampus, the den-
tate gyrus was also investigated due to its role in memory and
in neurogenesis (Neves et al., 2008). The cytokine TNF-α was
investigated due to its’ critical role in learning and memory.
Recent evidence suggests that a basal level of TNF-α is required
for normal memory and learning however excessive levels may
be detrimental (Baune et al., 2008; McAfoose and Baune, 2009;
Camara et al., 2013). Hippocampal TNF-α positive cells were
reduced in a dose dependent manner as shown by less TNF- α
positive cells with increasing -3 dietary concentration (One-
Way ANOVA F = 16.55, p < 0.001; Tukeys’ post-hoc test low
-3:-6 vs. medium -3:-6 p = 0.025, low -3:-6 vs. high
-3:-6 p = 0.0003, medium -3:-6 vs. high -3:-6 p =
0.041) (Figure 3A). Furthermore, when the dentate gyrus was
examined separately, the high-3:-6 diet mice had significantly
less TNF-α expression than low -3:-6 diet mice (One-Way
ANOVA F = 4.45, p = 0.038; Tukeys’ post-hoc test p = 0.036)
(Figure 3B). A representative image of TNF-α expression in
the dentate gyrus is depicted in Figure 4. These results sug-
gest that higher -3:-6 dietary ratio’s reduced the expression
of the pro-inflammatory cytokine TNF-α in the hippocampus
and the dentate gyrus.
EFFECTS OF-3:-6 SUPPLEMENTATION ON NEURONAL PROGENITOR
PROLIFERATION AND GLIOGENESIS MARKERS IN THE DENTATE GYRUS
To investigate the effect of -3 on neuronal progenitor prolifer-
ation, KI67 (proliferating cells) and DCX (immature neurons)
expression in the dentate gyrus were examined by staining hip-
pocampal slices with anti-Ki67 antibodies and anti-DCX antibod-
ies. Gliogenesis in the hippocampus was investigated by staining
of hippocampal slices with anti-GFAP (astrocyte marker) and
anti-IBA-1 (microglia marker) antibodies. The subsequent slides
were digitally imaged followed by manual examination.
Under physiological conditions, the high -3:-6 diet group
showed a significant increase in Ki67 and DCX positive cells
in the dentate gyrus compared to the low and medium -
3:-6 diet groups (Ki67: One-Way ANOVA F = 5.21 p = 0.026;
Tukeys’ post-hoc test p = 0.030, p = 0.048, respectively; DCX
One-Way ANOVA F = 6.70, p = 0.011; Tukeys’ post-hoc test
p = 0.0.035, p = 0.013, respectively) (Figures 5A,B). The rep-
resentative images of these stains can be viewed in Figures 6,
7. In contrast, dietary -3:-6 ratio content was found not
to modify microglia or astrocyte number in the hippocampus
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Table 3 | Serum cytokine levels.
Cytokines(pg/ml) TNF-α IFN-γ IL-6 IL-10 IL-12 MCP-1
Low -3:-6 4.59 ± 0.47 5.75 ± 1.87 3.57 ± 1.20 58.1 ± 17.5 20.6 ± 3.79 19.1 ± 4.35
Medium -3:-6 2.65 ± 0.36* 0.70 ± 0.27** 2.18 ± 0.64 23.8 ± 5.11 12.1 ± 1.51 18.7 ± 2.73
High -3:-6 2.39 ± 0.54* 1.03 ± 0.24** 2.07 ± 0.29 30.1 ± 6.46 15.4 ± 4.07 18.7 ± 2.46
Representation of cytokines in serum measured by CBA. Data analyzed by One-Way ANOVA with Tukey’s post-hoc test. *p < 0.05, **p < 0.01 C.F. low -3 diet.
Data represents mean ± SEM (n = 5/group).
FIGURE 3 | Total number of TNF-α positive cells in the hippocampus.
The total number of TNF-α positive cells in (A) the hippocampus (including
the dentate gyrus) and (B) the dentate gyrus only. Data analyzed by
One-Way ANOVA within strains with Tukey’s post-hoc test, ∗p < 0.05,
∗∗∗p < 0.001, as indicated on figure. All data presented as mean ± SEM
(n = 5/group).
[One-Way ANOVA microglia (IBA-1) F = 2.40, p = 0.13, astro-
cytes (GFAP) F = 0.20, p = 0.82] (representative images can be
seen in Supplementary Figures 1, 2). This indicates that the
increase in cell proliferation in high -3:-6 mice was not
associated with an increase in astrocyte or microglial number.
EFFECTS OF-3:-6 SUPPLEMENTATION ON OXIDATIVE STRESS AND
CELL DEATH IN THE DENTATE GYRUS
Oxidative stress was investigated through staining hippocam-
pal slices with an antibody to oxo8dG/oxo8G which measures
DNA/RNA oxidative damage. Dietary-3:-6 ratio modified the
level of oxidative stress, with a significant difference between the
median of each group (Kruskal Wallis p < 0.05), with the low -
3:-6 diet having a median of 2, representing moderate levels
of staining compared to a median of 1, indicating a low level of
staining in the medium and high -3:-6 diet groups (Figure 8).
Similarly, cell death was investigated through staining hip-
pocampal slices with anti-caspase 3 antibodies (a protein involved
in cell apoptosis) and examination of digital images. The dentate
gyrus was investigated to determine if the increase in cell prolif-
eration and immature neurons was associated with an increase
in cell death. Dietary -3:-6 ratio was not found to mod-
ify cell death in the dentate gyrus (One-Way ANOVA F = 0.54,
p = 0.59) (representative images can be viewed in Supplementary
Figure 3).
FREE FATTY ACID ANALYSIS OF THE HIPPOCAMPUS
Analysis of -3 and -6 concentrations in the hippocampus of
test mice confirmed that alterations in dietary levels of PUFAs do
translate to the brain and that mice did consume enough of the
pellets to see a change (Table 4). Concentration of -3 increased
from the low to high -3:-6 groups (One-Way ANOVA p =
0.0031) and Tukey’s post-hoc test showed that the low -3:-6
group had significantly lower levels of -3 in the hippocampus
than both the medium (p = 0.037) and high -3:-6 groups
(p = 0.0027). Concentration of -6 also decreased from the low
to high -3:-6 groups (One-Way ANOVA p = 0.0003) and
Tukey’s post-hoc test showed that the high -3:-6 group had
significantly lower levels of -6 in the hippocampus than both
the medium (p = 0.0022) and low-3:-6 groups (p = 0.0004).
Analysis of -3:-6 ratio in the hippocampus also confirmed
the expected differences based on diet. One-Way ANOVA (p <
0.0001) showed that the low -3:-6 group had a significantly
lower ratio than both the medium (p = 0.026) and high -3:-6
diets groups (p < 0.0001) while the medium -3:-6 diet group
also showed a significantly lower ratio than the high -3:-6 diet
group (p = 0.0022).
DISCUSSION
This study demonstrated that long-term supplementation and
increasing the dietary ratio of -3:-6 PUFA in unchallenged
mature adult (7 month old) WT mice leads to increased anxi-
ety and improved hippocampal dependent spatial memory, with
increases in neuronal progenitor proliferation and decreases in
TNF-α expression, as well as oxidative stress, within the hip-
pocampus. The effects on behavior, TNF-α expression and neu-
ronal progenitor proliferation appeared to be dose dependent,
with the high -3:-6 diet group demonstrating the highest
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FIGURE 4 | Representative images of TNF-α expression in the
dentate gyrus. Representative images of the hippocampus centered
on the dentate gyrus to demonstrate expression of TNF-α positive
cells at 20× magnification in (A) High -3:-6 mice, (B) medium
-3:-6 mice, (C) low -3:-6 mice and at 40× magnification in
(D–F), respectively. Arrows signify relevant stained cells.
FIGURE 5 | Effect of -3:-6 diet on neurogenesis in the
dentate gyrus. Number of KI67 positive cells (A) and DCX
positive cells (B) in the dentate gyrus. Data analyzed by
One-Way ANOVA within strains with Tukey’s post-hoc test,
∗p < 0.05 as indicated on figure. All data represented as mean
± SEM (n = 5/group).
levels of anxiety and significant learning in the Barnes Maze,
the lowest number of TNF-α positive cells within the hip-
pocampus, and the highest rate of neurogenesis whilst the low
-3:-6 diet group had the worst performance on the Barnes
Maze, the highest TNF-α expression and the highest levels of
oxidative stress. This suggests that -3 diet and -3:-6 ratios
may play an important role in maintaining normal behavior
throughout life.
The three different doses of -3 supplementation used in
this study were designed to represent relevant human equiva-
lent quantities of -3 and -6 consumption. The low -3:-6
diet corresponds to a typical western diet, the medium -3:-6
diet represents a physiologically traditional diet, while the high
-3:-6 diet represents considerably higher supplementation
again (Blasbalg et al., 2011; Simopoulos, 2011). As previously
discussed, increasing dietary -3 increases the -3:-6 ratio,
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 399 | 7
Grundy et al. Omega-3 supplementation in mice
FIGURE 6 | Representative images of DCX expression in the
dentate gyrus. Representative images of the hippocampus centered
on the dentate gyrus to demonstrate expression of DCX positive
cells at 20× magnification in (A) high -3:-6 mice, (B) medium
-3:-6 mice, (C) low -3:-6 mice and at 40× magnification in
(D–F), respectively. Arrows signify relevant stained cells.
allowing for higher concentrations of -3 derived metabolites to
form, which are considerably less pro-inflammatory than their
-6 derived counterparts (Wall et al., 2010). The use of spe-
cially designed lab diets based on the AIN-93M standard was
done to eliminate the inherent variability in standard lab chow
diets. It should be noted that for the first 2 months after wean-
ing, mice were fed with a standard diet (AIN- 93G) designed to
support a healthy development. Any effect of dietary -3:-6
supplementation thereafter can be attributed to the effect of -
3 supplementation and -6 reduction on adult central nervous
system function, and not due to -3 deficiency during neurode-
velopment, which has been previously documented (Gibson et al.,
2001; Salem et al., 2001; Ryan et al., 2010; Bhatia et al., 2011;
Rombaldi Bernardi et al., 2012). Furthermore, our modified diets
were given for 4 months (∼60% of lifespan), where supplemen-
tation >10% of lifespan has previously been suggested to be
beneficial (Hooijmans et al., 2012). Previous shorter-term studies
have demonstrated that 8 weeks of high -3 diet supplementa-
tion attenuated age related increases in TNF-α, IL-6 and IL-1β
and improved spatial memory as compared to an -3 deficient
diet (Labrousse et al., 2012). No previous studies using a treat-
ment as long as this one in unchallenged aged mice have been
performed. The longer-term supplementation given in this study
directs focus on the preventative actions of a high -3--6 PUFA
diet ratio in healthy, unchallenged mice up to middle age during
early adulthood. Our results represent evidence for a preventative
action of a high -3:-6 ratio against cognitive decline associ-
ated with early aging. It is important to note that higher dietary
-3:-6 dietary concentrations resulted in increased hippocam-
pal -3:-6 concentrations. This confirms that mice consumed
as adequate amount of each diet, and that dietary PUFA mod-
ulated brain PUFA concentration thus providing an explanation
for the central effects of ingested fatty acids. We did note that the
mice consuming the medium and high -3:-6 PUFA diet were
significantly heavier than the mice consuming the low -3:-6
diet. Previous reviews have linked obesity to higher levels of pro-
inflammatory cytokines (Lumeng and Saltiel, 2011), and thus, as
the higher-3:-6 PUFA diets resulted in reduced inflammation,
the weight of mice is unlikely to have played a role.
No differences in locomotor activity were seen in the open
field following different diets, however the high -3:-6 PUFA
diet led to lower time spent in the center of the open field, sug-
gesting increased anxiety. Previous studies investigating similar
parameters have shown varying results following -3 deficiency
or supplementation (Fedorova and Salem, 2006). For example,
several studies showed no difference between -3 deficient and
control mice (Nakashima et al., 1993; Carrié et al., 2000a), or
between high, low and normal -3: -6 diet groups, consistent
with our study (Wainwright et al., 1997). However, other stud-
ies have shown -3 deficient mice to have increased locomotor
activity (Umezawa et al., 1995; Raygada et al., 1998; Fedorova and
Salem, 2006) or mice given high -3 diets had reduced activity
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 399 | 8
Grundy et al. Omega-3 supplementation in mice
FIGURE 7 | Representative images of Ki67 expression in the
dentate gyrus. Representative images of the hippocampus centered
on the dentate gyrus to demonstrate expression of Ki67 positive
cells at 20× magnification in (A) high -3:-6 mice, (B) medium
-3:-6 mice, (C) low -3:-6 mice and at 40× magnification in
(D–F), respectively. Arrows signify relevant stained cells.
(Rockett et al., 2012), while further studies have shown differ-
ent effects of diet depending on age (Carrié et al., 2000b). All of
these studies have used different methods to measure locomotor
activity, as well as different dosing protocols, including the use
of different foods to increase or decrease -3 consumption and
either giving it directly to the study mice at different ages or giv-
ing it to the mother before and during gestation, therefore direct
comparison between studies is difficult. Similarly, various stud-
ies have shown different effects on anxiety behavior in animals
after altering -3:-6 PUFA levels in their diet (Fedorova and
Salem, 2006). -3 deficient mice have previously been shown
to have everything from decreased anxiety (Nakashima et al.,
1993; Francès et al., 1995), increased anxiety (Carrié et al., 2000a;
Fedorova and Salem, 2006), or no change in anxiety measured by
time spent in the open arm of an elevated plus maze (Belzung
et al., 1998; Moriguchi et al., 2000).
Despite the high -3:-6 PUFA diet leading to increased anx-
iety in the open field, as it has been suggested that anxiety may
exacerbate poor memory (Spencer et al., 2010), the -3:-6
PUFA ratio within the diet appears to be important for normal
cognition, with only the normal and high -3:-6 diet groups
showing normal learning across the 4 days on the Barnes Maze,
as shown by a significant decrease in escape latency from day 1 to
day 4. High -3:-6 supplementation may act through a variety
of mechanisms to support normal cognition. Here, it was found
that a low -3:-6 diet was associated with increased oxidative
stress within the dentate gyrus, with previous studies demon-
strating that oxidative stress contributes to age related impair-
ment in learning and memory (Liu et al., 2003). Furthermore,
it was found that a high -3:-6 diet ratio reduces the hip-
pocampal TNF-α expression. Whilst at basal levels cytokines
are intimately involved in cognitive processes (McAfoose and
Baune, 2009), their overexpression is associated with increased
risk of multiple neuropsychiatric disorders including cognitive
decline (McAfoose and Baune, 2009). As cognition-like behavior
improved in the high -3:-6 group while hippocampal TNF-
α including dentate gyrus TNF-α decreased, this may represent
a healthier concentration of TNF-α as compared to the low -
3:-6 group. Interestingly, this decrease in dentate gyrus TNF-a
coincided with increased neuronal progenitor proliferation. In
this study, -3 supplementation in conjunction with -6 restric-
tion also reduced systemic TNF-α and IFN-γ concentration. This
is likely to predominantly occur through increased -3 displac-
ing -6 from the common metabolic enzyme pathway leading to
increased -3 derived prostaglandins, leukotrienes, and throm-
boxanes which are less pro-inflammatory than their -6 derived
counterparts (Tassoni et al., 2008; Farooqui, 2009; Wall et al.,
2010). Additionally, cell culture studies have demonstrated that
-3 down regulates the p38 MAPK signaling pathway result-
ing in decreased nitric oxide synthase, decreasing nitric oxide,
TNF-α and prostaglandin E2 (Antonietta Ajmone-Cat et al.,
2012). Furthermore,-3 promotes the production of peroxisome
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 399 | 9
Grundy et al. Omega-3 supplementation in mice
FIGURE 8 | Effect of -3:-6 diet on oxidative stress in the
dentate gyrus. Representative images of oxo8dG/oxo8G
expression in the dentate gyrus at 20× magnification in (A)
high -3:-6 mice, (B) medium -3:-6 mice, (C) low -3:-6
mice, with representation of the median intensity of staining in
each group (D).
proliferator-activated receptor (PPAR)-γ, which is known to reg-
ulate microglia and astrocyte cytokine production. Lastly,-3 has
been demonstrated to reduce pathological microglia and astro-
cyte activation which occurs with aging (Gupta et al., 2012;
Labrousse et al., 2012). The modulation of systemic and cen-
tral inflammation together appears to promote a neuroprotective
environment in these unchallenged mature adult (7 month old)
WT mice.
Evidence regarding the actions of -6 suggests that while it is
an essential fatty acid and necessary in small amounts for good
health, large quantities such as in current western diets have been
shown to have a detrimental and pro-inflammatory effect (Wall
et al., 2010; Blasbalg et al., 2011; Simopoulos, 2011). Thus, the
reduction of-6 PUFA in the high-3:-6 diet may also be con-
tributing to the protective actions of this diet that were observed
in our study.
Further potential mechanisms of improved cognition include
the promotion of neuronal progenitor proliferation, which was
only noted in mice given the high -3:-6 diet. Increased
neurogenesis in the subgranular zone of the hippocampus in
young mice (Valente et al., 2009), and in cell culture (Antonietta
Ajmone-Cat et al., 2012), have previously been shown to occur
with -3 supplementation. This is likely to occur through
increased BDNF levels (Jiang et al., 2009), while -3 deprivation
has previously been shown to decrease BDNF and phosphorylated
CMP response element binding protein (pCREB) (Bhatia et al.,
2011). This is the first study to demonstrate that a high -3:-6
diet supports adult neurogenesis (as measured by Ki67 and DCX
expression in the dentate gyrus). A high -3:-6 dietary ratio
has been demonstrated to have these effects in an approximately
middle-age (7 months old) mouse model, supporting a preventa-
tive action of -3 PUFA against cognitive decline, thus, investiga-
tion of long-term supplementation in young-middle aged human
populations may be astute.
In contrast to the demonstrated effects on hippocampal TNF-
α levels and on neurogenesis, no effect of diet was demonstrated
on astrocyte number ormicroglia number in this hippocampus of
this unchallenged mouse model. Current literature suggests that
inappropriate microglia activation plays a key degenerative role
in the progression of cognitive decline (Antonietta Ajmone-Cat
et al., 2012; Czirr andWyss-Coray, 2012). This study suggests that
in an unchallenged mouse model, increased microglia number is
not amajor contributing factor and other mechanisms such as the
promotion of neuronal progenitor proliferation and modulation
of cytokine activity may be more significant.
In clinical studies of age related cognitive decline (ARCD) uti-
lizing -3 supplementation, the dose administered varies from
400mg/day (Geleijnse et al., 2012) to 2800mg/day (Van De Rest
et al., 2008), while doses of up to 9600mg/day have been trialed in
depression. These doses, supplemented to a typical western diet,
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Table 4 | Hippocampus PUFA levels.
-3 (% Free -6 (% Free -3:-6
fatty acids) fatty acids)
Low -3:-6 10.2 ± 0.61 22.7 ± 0.78 0.45 ± 0.01
Medium -3:-6 12.7 ± 0.62* 22.1 ± 0.71 0.58 ± 0.03*
High -3:-6 13.8 ± 0.54** 18.0 ± 0.25***,## 0.77 ± 0.04****,##
Representation of -3 -6 PUFA levels measured in hippocampus. Data ana-
lyzed by One-Way ANOVA with Tukey’s post-hoc test. *C.F. low -3 diet, ##C.F.
medium -3:-6 diet. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Data represents mean ± SEM (n = 5/group).
result in -3:-6 PUFA ratios of slightly less than the medium
-3 supplementation diet in this study (Blasbalg et al., 2011). The
total fat intake of this study was standardized to 5%making quan-
tification of human equivalent intakes speculative. Fat restriction
allows for precise manipulation of the -3:-6 ratio without
using large quantities of -3 PUFA and the increased energy con-
tent that comes with fat ingestion. Specifically, in a fat restricted
diet, relatively smaller increase in -3 content corresponds to a
greater change in-3:-6 ratio. Thus, achieving a similar-3:-
6 ratio as the high -3 mouse diet would require considerable
fat restriction, or a targeted reduction of -6 intake (Blasbalg
et al., 2011). It will be necessary to monitor whether increasing
the dose in future clinical trials proves more efficacious, although
considerationmust bemade to investigating dietary fat restriction
coupled with -3 supplementation.
In conclusion, long-term -3 supplementation coupled with
-6 restriction was demonstrated to increase anxiety, improve
cognitive function, reduce TNF-α expression and enhance neu-
ronal progenitor proliferation in unchallenged mature adult (7
month old) mice. These results support the view that in transla-
tional research, the preventive effects of a long-term high-3:-6
diet in older adults at risk of cognitive decline require further
investigation, also addressing the dose required to result in clin-
ically demonstrable preventive effects on cognitive function. It
is unclear however whether supplementation such as used in
the current study would overcome a long term significantly pro-
inflammatory insult. Further trials investigating -3 supplemen-
tation in long term, pro-inflammatory conditions may provide
further insight into the efficacy of a high -3:-6 diet in such
conditions. Future studies should also include a wider range of
behavioral tests, to confirm the effects of -3:-6 ratio in diet on
anxiety and cognition, at a range of ages up to old age in mice.
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